Starting on page 128, right column under the heading Recurrence-Free Survival, the second sentence should read as follows: "Of the other 133 (28%) patients whose events are included in this analysis, 105 (79%) had disease recurrence (46 in the adjuvant chemotherapy arm and 59 in the no-adjuvant-chemotherapy arm) and 26 (20%) had died without recurrence (eight in the adjuvant chemotherapy arm and 18 in the no-adjuvant-chemotherapy arm), a further two patients (<1%, one in each arm) have died with no information being available on whether or not they had a recurrence prior to death."
The numbers of patients in the CONSORT flow diagram (Fig. 1, page 128) should include the following: In the patients allocated immediate treatment (bottom left box), 186 (77%) alive no recurrence, 13 (5%) alive without recurrence. In the patients allocated no-immediate-adjuvant treatment (bottom right box), 158 (67%) alive no recurrence, 17 (7%) alive with recurrence.
The authors regret the error.
![]() |
||||
|
Oxford University Press Privacy Policy and Legal Statement |